Robert W. Colman
Sol Sherry Thrombosis Research Center
Temple University School of Medicine
Philadelphia
PA 19140
USA
Name/email consistency: high
- The contact system and angiogenesis: potential for therapeutic control of malignancy. Colman, R.W. Semin. Thromb. Hemost. (2004)
- Platelet cyclic adenosine monophosphate phosphodiesterases: targets for regulating platelet-related thrombosis. Colman, R.W. Semin. Thromb. Hemost. (2004)
- Inhibition of angiogenesis by a monoclonal antibody to kininogen as well as by kininostatin which block proangiogenic high molecular weight kininogen. Colman, R.W. Int. Immunopharmacol. (2002)
- Domain 5 of high molecular weight kininogen (kininostatin) down-regulates endothelial cell proliferation and migration and inhibits angiogenesis. Colman, R.W., Jameson, B.A., Lin, Y., Johnson, D., Mousa, S.A. Blood (2000)
- Kininogens are antithrombotic proteins In vivo. Colman, R.W., White, J.V., Scovell, S., Stadnicki, A., Sartor, R.B. Arterioscler. Thromb. Vasc. Biol. (1999)
- Plasma and tissue kallikrein in arthritis and inflammatory bowel disease. Colman, R.W. Immunopharmacology (1999)
- Biologic activities of the contact factors in vivo--potentiation of hypotension, inflammation, and fibrinolysis, and inhibition of cell adhesion, angiogenesis and thrombosis. Colman, R.W. Thromb. Haemost. (1999)
- The plasma kallikrein-kinin system in sepsis, inflammatory arthritis, and enterocolitis. Colman, R.W., Sartor, R.B., Adam, A.A., DeLa Cadena, R.A., Stadnicki, A. Clin. Rev. Allergy. Immunol (1998)